Drug Abuse Testing Market Report By Product & Services (Analysers, Rapid Testing Devices, Consumables, Laboratory Services), Sample Type (Urine, Oral Fluid, Breath, Hair, Others), Drug Type (Alcohol, Cannabis/Marijauna, Cocaine, Opioids, Amphetamine & Methaphetamine, LSD, Others), End Users (Drug Testing Laboratories, Workplaces, Hospitals, Rehabilitation Centers, Academic Institutes and Research Centers, Others) Countries and Company Analysis 2024-2032
Buy NowGlobal Drug Abuse Testing Market Analysis
Drug Abuse Testing Market will reach US$ 11.87 billion by 2032, up from US$ 6.17 billion in 2023, with a CAGR of 7.54% between 2024 and 2032.
Drug Abuse Testing Outlooks
Drug abuse is often described as the administration of unlawful substances or the continued use of OTC’s and legal prescriptions that have been given to treat conditions that cause excitement or increased performance. In addition, you can affect the physical and mental state and is able to cause several diseases and addictions. For this reason, it is detected in individuals using a number of diagnostic methods to manage other diseases with the help of which it is linked. It also aids in confirming youngsters and infants who might have been exposed to unlawful drugs and the acute psychiatric stability and epilepsy crises in the Emergency Room. It is used especially in office before offering a job to a candidate.
Report Features | Details |
Base Year |
2023 |
Forecast Years |
2024 - 2032 |
Historical Years |
2019 - 2023 |
Market Size in 2023 |
US$ 6.17 Billion |
Market Forecast in 2032 |
US$ 11.87 Billion |
Market Growth Rate (2024-2032) |
7.54% |
Driving Forces for Drug Abuse Testing
High Alcohol and drug consumption: Alcohol and drug use are increasing worldwide. According to the WHO’s World Drug Report published in 2023, 1in 7 people globally aged 15-24, reported using drugs in 2022. There were more users – 240 million in 2011 and 296 million in 2021, or 5.8 percent of the population of the entire world in the age range of 15 and 64 years. Other substances are marijuana, which is projected to be the second most used drug in 2021 with Its users of 219 million, or 4.3%. According to the Communication from the National Highway Traffic Safety Administration of the US Department of Transportation, 13,384 people died in alcohol- impaired driving crashes in 2021 with a 14% rise compared to 2020. The increasing incidences of Alcohol and the use of illegal Substances will drive the Mobile drug testing methods and solution hence driving the market in its entirety.
Awareness Programs: Consumer awareness initiative is very instrumental in developing the market of drug misuse testing. They raise the public awareness of the effects of drug taking hence create a market for the testing services. Also, they promote the best practice in testing as well as regulation, turning the concept of drug testing into a more proactive approach. This raised awareness contributes to a sustainable market growth because it influences the regulation decisions, diversification into new sectors, and development of the testing technologies.
Technological Advancement: Technological advances present the drug abuse testing market with major opportunities that contribute greatly to its growth, the advances constantly improve the testing processes’ efficacy, accuracy, and flexibility. Technological advancements in drug tests are achieved in increased sensitization through enhanced; mass spectrometry equipment, better chromatography procedures, and rapid point of care testing. They expand the range of possible substances: new drugs and new generation redirected substances and enhance the speed and accuracy of identification.
Moreover, since technology is continuously innovated, test outcomes are usually given promptly, and this could enhance speedy decision making such as in business establishments, hospitals, and law enforcement agencies. Higher sensitivity and specificity of testing procedures enhance dependability of results thus providing confidence to the users as well as the regulatory bodies in the outcome of screenings. Technological advances drive market growth due to various business requirements, the ability to address rigorous legislation, and continuous exchange in substance abuse tests, which collectively increase the need for more sophisticated testing services.
North America Drug Abuse Testing Market
The requirement for drug abuse testing in North America is expected to grow due to the higher number of accidents, people affected by addiction, an uptrend in the usage in the workplace, and the solid healthcare infrastructure. Furthermore, it is stated that 70 percent addicts found by the National Council on Alcoholism & Drug Dependence (NCADD) are employed. Primary the employments, 14.8 million Americans abuse drugs while they have their employment. Likewise, more than 74% of today’s current illegal drug users are employed; they account for up to 40% of workplace deaths in the US as stated by the National Drug-Free Workplace Alliance.
Also, The People’s Republic of China’s Ministry of Foreign Affairs revealed that a large proportion of the American drug consumers has engaged in cannabis, prescription stimulants, opioids, methamphetamine, heroin, and cocaine. This has therefore called for drug test in work office to enhance safety and health of the workers.
Drug Abuse Testing Company Analysis
The top drug abuse testing companies are Danaher Corporation, LabCorp, Abbott Laboratories, Quest Diagnostics, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Ltd., and Medtronic Plc.
Drug Abuse Testing Company News
In February 2024, OraSure Technologies Inc. (OSUR) highlighted solid financial performance during its profit call, with increased operating income, expanded gross margins, and a robust cash balance.
In February 2024, Veriteque (US) and OraSure Technologies (US) agreed to a distribution deal for SwabTek test kit products. OraSure's oral fluid screening solutions will complement Veriteque's SwabTek brand presumptive field test kits.
In December 2023, Quest Diagnostics (US) launched a new confirmatory testing service for novel psychoactive substances (NPS). The panel tests cover 88 different compounds from various drug classes, including synthetic cannabinoids, designer stimulants, opioids, benzodiazepines, fentanyl analogs, and other additives found in illicit drugs.
In July 2023, seven global regulators intend to seek medical approvals from the MHRA in the Euro Roundup.
In August 2022, The Delaware Division of Public Health added fentanyl strips to Narcan kits to prevent unintentional overdoses from fentanyl use.
FAQs
Question: What is the current size of the global drug abuse testing market?
Answer: The global drug abuse testing market was valued at US$ 6.17 Billion in 2023.
Question: What will be the market size of drug abuse testing market by 2032?
Answer: The market will grow at a steady CAGR of 7.53% between 2024 and 2032, capturing a valuation of US$ 11.87 Billion in 2032.
Question: What factors are driving the growth of the drug abuse testing market?
Answer: Factors driving growth include increasing demand for drug abuse treatment, stringent laws mandating alcohol and drug testing, rising drug-related mortality, and increasing government initiatives.
Question: What challenges does the drug abuse testing market face?
Answer: Challenges include perceptions of drug abuse testing as a violation of rights and lack of awareness regarding the availability of advanced drug testing devices.
Question: Who are the major players in the drug abuse testing market?
Answer: Major players in drug abuse testing market include Danaher Corporation, LabCorp, Abbott Laboratories, Quest Diagnostics, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Ltd. and Medtronic Plc.
Product & Services – Market breakup in 4 viewpoints:
- Analysers
- Rapid Testing Devices
- Consumables
- Laboratory Services
Sample Type – Market breakup in 5 viewpoints:
- Urine
- Oral Fluid
- Breath
- Hair
- Others
Drug Type – Market breakup in 7 viewpoints:
- Alcohol
- Cannabis/Marijauna
- Cocaine
- Opioids
- Amphetamine & Methaphetamine
- LSD
- Others
Country – Market breakup of 25 Countries:
- North America
1.1 United States
1.2 Canada
- Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
- Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
- Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
- Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the key players have been covered from 4 Viewpoints:
- Business Overview
- Product Portfolio
- Recent Development & Strategies
- Revenue Analysis
Key Players Analysis:
- Danaher Corporation
- LabCorp
- Abbott Laboratories
- Quest Diagnostics
- Thermo Fisher Scientific Inc.
- Hoffmann-La Roche Ltd.
- Bio-Rad Laboratories Ltd.
- Medtronic Plc.
Report Details:
Report Features | Details |
Base Year |
2023 |
Historical Period |
2019 - 2023 |
Forecast Period |
2024 - 2032 |
Market |
US$ Billion |
Segment Covered |
Products & Services, Sample Type, Drug Type, End User, and Countries |
Countries Covered |
|
Companies Covered |
|
Customization Scope |
20% Free Customization |
Post-Sale Analyst Support |
1 Year (52 Weeks) |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Drug Abuse Testing Market
6. Market Share
6.1 By Product & Service
6.2 By Sample Type
6.3 By Drug Type
6.4 By End Users
6.5 By Countries
7. Product & Service
7.1 Analysers
7.2 Rapid Testing Devices
7.3 Consumables
7.4 Laboratory Services
8. Sample Type
8.1 Urine
8.2 Oral Fluid
8.3 Breath
8.4 Hair
8.5 Others
9. Drug Type
9.1 Alcohol
9.2 Cannabis/Marijauna
9.3 Cocaine
9.4 Opioids
9.5 Amphetamine & Methaphetamine
9.6 LSD
9.7 Others
10. End Users
10.1 Drug Testing Laboratories
10.2 Workplaces
10.3 Hospitals
10.4 Rehabilitation Centers
10.5 Academic Institutes and Research Centers
10.6 Others
11. Countries
11.1 North America
11.1.1 United States
11.1.2 Canada
11.2 Europe
11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherland
11.2.8 Turkey
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 Australia
11.3.5 South Korea
11.3.6 Thailand
11.3.7 Malaysia
11.3.8 Indonesia
11.3.9 New Zealand
11.4 Latin America
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.5 Middle East & Africa
11.5.1 South Africa
11.5.2 Saudi Arabia
11.5.3 UAE
12. Porter’s Five Forces Analysis
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat
14. Key Players Analysis
14.1 Danaher Corporation
14.1.1 Overview
14.1.2 Product Portfolio
14.1.3 Recent Development
14.1.4 Revenue Analysis
14.2 LabCorp
14.2.1 Overview
14.2.2 Product Portfolio
14.2.3 Recent Development
14.2.4 Revenue Analysis
14.3 Abbott Laboratories
14.3.1 Overview
14.3.2 Product Portfolio
14.3.3 Recent Development
14.3.4 Revenue Analysis
14.4 Quest Diagnostics
14.4.1 Overview
14.4.2 Product Portfolio
14.4.3 Recent Development
14.4.4 Revenue Analysis
14.5 Thermo Fisher Scientific Inc.
14.5.1 Overview
14.5.2 Product Portfolio
14.5.3 Recent Development
14.5.4 Revenue Analysis
14.6 F. Hoffmann-La Roche Ltd.
14.6.1 Overview
14.6.2 Product Portfolio
14.6.3 Recent Development
14.6.4 Revenue Analysis
14.7 Bio-Rad Laboratories Ltd.
14.7.1 Overview
14.7.2 Product Portfolio
14.7.3 Recent Development
14.7.4 Revenue Analysis
14.8 Medtronic Plc.
14.8.1 Overview
14.8.2 Product Portfolio
14.8.3 Recent Development
14.8.4 Revenue Analysis
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com